# A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.

> **NCT07523100** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Daishi Tian** · enrollment: 24 (estimated)

## Conditions studied

- Multiple Sclerosis (MS)

## Interventions

- **DRUG:** Universal STAR-T Cell Injection

## Key facts

- **NCT ID:** NCT07523100
- **Lead sponsor:** Daishi Tian
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-07
- **Primary completion:** 2027-04-01
- **Final completion:** 2029-04-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07523100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07523100, "A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07523100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*